XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Shareholders' Equity
 6 Months Ended
Jun. 30, 2024
Shareholders' Equity  
Shareholders' Equity

8. Shareholders' Equity

 

 

 

Three months ended June 30,

 


Six months ended June 30,

 

 

2024

 

 

2023

 


2024

2023

Common stock and additional paid-in capital

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

31,608

 

 

$

74,957

 


$ 46,071

$
 74,934

Dividends declared

 


—

 


(28,979

)

(14,496 )

(28,979 )

Share-based compensation expense

 

 

39

 

 

 

25

 



65


47

Proceeds from employee stock purchase plan

 

 

(7

 )

 

 

—

 



—


1

Balance, end of period

 

$

31,640

 

 

$

46,003

 


$ 31,640

$ 46,003

 

 

 

 

 

 

 

 

 









Accumulated other comprehensive loss

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(290

 )

 

$

(283

 )
$ (310 )
$ (288 )

Unrealized loss on available-for-sale securities, net of tax 

 

 

(3

 )

 

 

14

19


14

Foreign currency translation adjustment

 

 

(1

 )

 

 

(1

 )

(3 )

4

Balance, end of period

 

$

(294

 )

 

$

(270

 )
$ (294 )
$ (270 )

 

 

 

 

 

 

 

 

 









Accumulated deficit 

 

 

 

 

 

 

 

 









Balance, beginning of period

 

$

(2,972

 )

 

$

(1,348

 )
$ (1,076 )
$ (516 )

Net loss

 

 

(2,822

 )

 

 

(1,019

)



(4,718 )

(1,851 )

Balance, end of period

 

$

(5,794

 )

 

$

(2,367

)


$ (5,794 )
$ (2,367 )

 

 

 

 

 

 

 

 

 









Total shareholders' equity

 

$

25,552

 

 

$

43,366

 


$ 25,552

$ 43,366

 

Issue of Common Stock and Warrants


On September 12, 2021, the Company entered into a securities purchase agreement with certain purchasers named therein, pursuant to which the Company issued 3,623,189 shares of the Company's common stock, par value $0.001 per share at an offering price of $2.76 per share. The Company received gross proceeds of approximately $10,000 and net proceeds of $9,288 after deducting placement agent fees and related offering expenses. In a concurring private placement the Company also issued to the same purchasers warrants exercisable for an aggregate of 3,623,189 shares of common stock at an exercise price of $2.76 per share. Each warrant became immediately exercisable and will expire on March 15, 2027.


On January 4, 2022, the Company entered into a Securities Purchase Agreement with Edward D. Bagley, an affiliate of the Company, pursuant to which the Company agreed to issue and sell, in a private placement 1,538,461 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share, at a purchase price of $1.30 per share of Common Stock. The consideration for the Shares is the cancellation and termination of Mr. Bagley’s outstanding bridge loan to the Company in the principal amount of $2,000 originally issued on July 2, 2021 and amended and restated on September 11, 2021. Mr. Bagley is an affiliate of the Company and the Company’s single largest stockholder.